ClinicalTrialsFinder

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG Clinical Trials in London, Ontario

1 recruitingLondon, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 2

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc.90 enrolled16 locationsNCT03945162